However, to address exercise intolerance more comprehensively, OM may need to be combined with adjunctive therapies that target skeletal muscle perfusion, microvascular dysfunction, or mitochondrial bioenergetics, such as SGLT2 inhibitors, exercise training, or novel metabolic modulators. Here, SLC5A2 is linked to ocular melanoma.